Pharmacode position may change as per Supplier's m/c requirement &additional small pharma code may appear on the front / back panel

J    L

Package Leaflet: Information for the patient

Levetiracetam Milpharm 100 mg/ml oral solution

Levetiracetam

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

-    Keep this leaflet. You may need to read it again.

-    If you have any further questions, ask your doctor or pharmacist.

-    This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

-    If you get any side effects talk to your doctor or pharmacist.This includes any possible side effects not listed in this leaflet.

What is in this leaflet:

1.    What Levetiracetam Milpharm is and what it is used for

2.    What you need to know before you take Levetiracetam Milpharm

3.    How to take Levetiracetam Milpharm

4.    Possible side effects

5.    How to store Levetiracetam Milpharm

6.    Contents of the pack and other information

1. What Levetiracetam Milpharm is and what it is used for

Levetiracetam Milpharm 100 mg/ml oral solution is an antiepileptic

medicine (a medicine used to treat seizures in epilepsy).

Levetiracetam Milpharm is used:

•    on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy, to treat partial onset seizures with or without secondary generalisation

•    as an add-on to other antiepileptic medicines to treat:

•    partial onset seizures with or without generalisation in adults, adolescents, children and infants from one month of age

•    myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.

•    primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

2. What you need to know before you take Levetiracetam Milpharm

Do not take Levetiracetam Milpharm

•    If you are allergic (hypersensitive) to levetiracetam or any of the other ingredients of this medicine (listed in Section 6).

Warnings and Precautions

Talk to your doctor before taking Levetiracetam Milpharm

•    If you suffer from kidney problems, follow your doctor’s instructions. He/she may decide if your dose should be adjusted.

•    If you notice any slow down in the growth or unexpected puberty development of your child, please contact your doctor.

•    If you notice an increase in seizure severity (e.g. increased number), please contact your doctor.

•    A small number of people being treated with anti-epileptics such as Levetiracetam Milpharm have had thoughts of harming or killing themselves. If you have any symptoms of depression and/or suicidal ideation, please contact your doctor.

Other medicines and Levetiracetam Milpharm

Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.

Levetiracetam Milpharm with food, drink and alcohol

You may take Levetiracetam Milpharm with or without food. As a safety precaution, do not take Levetiracetam Milpharm with alcohol.

Pregnancy and breast-feeding

Ask your doctor or pharmacist for advice before taking any medicine.

If you are pregnant or if you think you may be pregnant, please inform your doctor.

Levetiracetam Milpharm should not be used during pregnancy unless clearly necessary. A risk of birth defects for your unborn child cannot be completely excluded. Levetiracetam has shown unwanted reproductive effects in animal studies at dose levels higher than you would need to control your seizures.

Breast-feeding is not recommended during treatment.

Driving and using machines

Levetiracetam Milpharm may impair your ability to drive or operate any tools or machinery, as Levetiracetam Milpharm may make you feel sleepy. This is more likely at the beginning of treatment or after an increase in the dose. You should not drive or use machines until it is established that your ability to perform such activities is not affected.

Important information about some of the ingredients of Levetiracetam Milpharm

Levetiracetam Milpharm oral solution includes methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) which may cause allergic reactions (possibly delayed).

Levetiracetam Milpharm oral solution contains maltitol. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

3. How to take Levetiracetam Milpharm

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor if you are not sure.

Levetiracetam Milpharm must be taken twice a day, once in the morning and once in the evening, at about the same time each day. Take the oral solution following your doctor’s instructions.

Monotherapy

Dose in adults and adolescents (from 16 years of age):

General dose: between 10 ml (1000 mg) and 30 ml (3000 mg) each day, divided in 2 intakes per day. When you will first start taking Levetiracetam Milpharm, your doctor will prescribe you a lower dose during 2 weeks before giving you the lowest general dose.

Add-on therapy

Dose in adults and adolescents (12 to 17 years) weighing 50 kg or more:

General dose: between 10 ml (1000 mg) and 30 ml (3000 mg) each day, divided in 2 intakes per day.

Dose in infants (6 to 23 months), children (2 to 11 years) and adolescents (12 to 17 years) weighing less than 50 kg:

Your doctor will prescribe the most appropriate pharmaceutical form of Levetiracetam Milpharm according to the age, weight and dose.

General dose: between 0.2 ml (20 mg) and 0.6 ml (60 mg) per kg bodyweight each day, divided in 2 intakes per day. The exact quantity of oral solution formulation should be delivered using the syringe provided in the cardboard box.

Dose in infants (1 month to less than 6 months):

General dose: between 0.14 ml (14 mg) and 0.42 ml (42 mg) per kg bodyweight each day, divided in 2 intakes per day. The exact quantity of oral solution formulation should be delivered using the syringeprovided in the cardboard box.

Method of administration:

Levetiracetam Milpharm oral solution may be diluted in a glass of water or baby’s bottle.

Instructions for use:

•    Open the bottle: press the cap and turn it anticlockwise (figure 1)

•    Separate the adaptor from the syringe (figure 2). Insert the adaptor into the bottle neck (figure 3). Ensure it is well fixed.

• Take the syringe and put it in the adaptor opening (figure 4). Turn the bottle upside down (figure 5).

• Fill the syringe with a small amount of solution by pulling the piston down (figure 5 A), then push the piston upward in order to remove any possible bubble (figure 5 B). Pull the piston down to the graduation mark corresponding to the quantity in milliliters (ml) prescribed by your doctor (figure 5 C).

• Turn the bottle the right way up (figure 6A). Remove the syringe from the adaptor (figure 6B).

• Empty the contents of the syringe in a glass of water or baby’s bottle by pushing the piston to the bottom of the syringe (figure 7).

•    Drink the whole contents of the glass/baby’s bottle.

•    Close the bottle with the plastic screw cap.

•    Wash the syringe with water only (figure 8)

Duration of treatment:

•    Levetiracetam Milpharm is used as a chronic treatment. You should continue Levetiracetam Milpharm treatment for as long as your doctor has told you.

•    Do not stop your treatment without your doctor’s advice as this could increase your seizures. Should your doctor decide to stop your Levetiracetam Milpharm treatment, he/she will instruct you about the gradual withdrawal of Levetiracetam Milpharm.

If you take more Levetiracetam Milpharm than you should:

The possible side effects of an overdose of Levetiracetam Milpharm are sleepiness, agitation, aggression, decrease of alertness, inhibition of breathing and coma.

Contact your doctor if you took more Levetiracetam Milpharm than you should. Your doctor will establish the best possible treatment of overdose.

If you forget to take Levetiracetam Milpharm:

Contact your doctor if you have missed one or more doses. Do not take a double dose to make up for a forgotten dose.

If you stop taking Levetiracetam Milpharm:

If stopping treatment, as with other antiepileptic medicines, Levetiracetam Milpharm should be discontinued gradually to avoid an increase of seizures.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although

not everybody gets them.

Some of the side effects like sleepiness, tiredness and dizziness

may be more common at the beginning of the treatment or at dose

increase. These effects should however decrease over time.

Very common: may affect more than 1 user in 10

•    nasopharyngitis;

•    somnolence (sleepiness), headache.

Common: may affect 1 to 10 users in 100

•    anorexia (loss of appetite);

•    depression, hostility or aggression, anxiety, insomnia, nervousness or irritability;

•    convulsion, balance disorder (equilibrium disorder), dizziness (sensation of unsteadiness), lethargy, tremor (involuntary trembling);

•    vertigo (sensation of rotation);

•    cough;

•    abdominal pain, diarrhoea, dyspepsia (indigestion), vomiting, nausea;

•    rash;

•    asthenia/fatigue (tiredness).

Uncommon: may affect 1 to 10 users in 1000

•    decreased number of blood platelets, decreased number of white blood cells;

•    weight decrease, weight increase;

•    suicide attempt and suicidal ideation, mental disorder, abnormal behaviour, hallucination, anger, confusion, panic attack, emotional instability/mood swings, agitation;

•    amnesia (loss of memory), memory impairment (forgetfulness), abnormal coordination/ataxia (impaired coordinated movements), paraesthesia (tingling), disturbance in attention (loss of concentration);

•    diplopia (double vision), vision blurred;

•    liver function test abnormal;

•    hair loss, eczema, pruritus;

•    muscle weakness, myalgia (muscle pain);

•    injury.

Rare: may affect 1 to 10 users in 10,000

•    infection;

•    decreased number of all blood cell types;

•    severe hypersensitivity reactions (DRESS);

•    decreased blood sodium concentration

•    suicide, personality disorders (behavioural problems), thinking abnormal (slow thinking, unable to concentrate);

•    uncontrollable muscle spasms affecting the head, torso and limbs, difficulty in controlling movements, hyperkinesia (hyperactivity);

•    pancreatitis;

•    hepatic failure, hepatitis;

•    skin rash, which may form blisters and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge) (erythema multiforme), a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (Stevens-Johnson syndrome), and a more severe form causing skin peeling in more than 30% of the body surface (toxic epidermal necrolysis).

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet.

Also you can help to make sure that medicines remain as safe as possible by reporting any unwanted side effects via the internet at www.mhra.gov.uk/yellowcard. Alternatively you can call Freephone 0808 100 3352 (available from 10 a.m. to 2 p.m. Mondays to Fridays) or fill in a paper form available from your local pharmacy.

5. How to store Levetiracetam Milpharm

Keep this medicine out of the sight and reach of children.

This medicinal product does not require any special storage conditions.

Do not use after 7 months of first opening the bottle.

Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Levetiracetam Milpharm contains

• The active substance is called levetiracetam. Each ml contains 100 mg of levetiracetam.

The other ingredients are: maltitol liquid (E965), glycerol (E422), propylene glycol, methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), citric acid monohydrate, sodium citrate (dihydrate), acesulfame potassium (E950), mafco magnasweet (Glycerine Monoammonium glycyrrhizinate), grape flavour (flavourings, propylene glycol, ascorbic acid), purified water.

What Levetiracetam Milpharm looks like and contents of the pack

Levetiracetam Milpharm 100 mg/ml oral solution is a clear, colourless, grape flavoured liquid.

300 ml amber glass bottle (type III) with a white child resistant closure in a cardboard box also containing a 10 ml graduated oral syringe and an adaptor for the syringe.

150 ml amber glass bottle (type III) with a white child resistant closure in a cardboard box also containing a 3 ml graduated oral syringe and an adaptor for the syringe.

150 ml amber glass bottle (type III) with a white child resistant closure in a cardboard box also containing a 1 ml graduated oral syringe and an adaptor for the syringe.

Not all pack sizes may be marketed.

Marketing Authorization Holder

Milpharm Limited Ares, Odyssey Business Park West End Road South Ruislip HA4 6QD United Kingdom

Manufacturer

APL Swift Services (Malta) Limited HF26, Hal Far Industrial Estate, Hal Far Birzebbugia, BBG 3000 Malta

This leaflet was last revised in 05/2014.